|
Doctors are running out of antibiotics to treat
some infections that can kill vulnerable people in the hospital
and is rapidly spreading in the community infecting health adults
and children. CDC published a statement “Children born after 2002
are more likely to die before their parents” is depressing for
parents with children. WHO have estimated the number of people
colonized with antibiotic resistant bacteria in the world to be
around 53 million.
Experts are urging drug companies not to give
up an area of research they consider unprofitable. Although the
pharmaceutical industry have developed new antibiotics to treat
the so-called hospital superbug MRSA (methycillin-resistant
Staphylococcus aureus), the pipeline for drugs to treat some other
infections was practically dry.
The cost of developing a new drug is usually
said to be somewhere between $500m (£285m) and $1bn, depending on
whether the many drugs that fail are costed in and whether the
marketing budget is included.
Antibiotics were not a priority for the
pharmaceutical industry, but they remained a critical area for
public health. Most troubling now is the rise of what are known as
gram negative bacteria (MRSA is gram positive) which are becoming
resistant to antibiotics. These include E coli, which can cause
serious food poisoning, Acinetobacter, which can kill those whose
immune system is compromised,
Streptococcus Pneumoniae Serotype
19A producing meningitis in immunised children and Pseudomonas,
which particularly attacks cystic fibrosis patients.

Doctors and patients are advised to do their
bit to prolong the life of antibiotics by not over-using them by
Health Care Commission, NICE and the Politicians. NHS has published
leaflets to educate patients not ask for them to treat coughs and
colds, which are caused by viruses, not bacteria, but this policy
is difficult to implement due to lack of support to doctors.
Clinically it is difficult to differentiate viral from bacterial
infections but the courts have penalised doctors when this mistake
occurs. Patients confidence has been undermined and they do not
trust doctor’s clinical hunch and so demand antibiotics. Saying no
to antibiotic results in failed consultation and the doctors are
blamed and victimised due to NHS complaint policy.
Resistance to antibiotics has now spread around
the world in a way it did not in past decades. Fifty years ago,
resistance that developed in India stayed in India but now it is
here, unfortunately we are not prepared. Resistance is just
evolution in real time. It just happens quicker with germs than in
rats and humans. Penicillin's introduction in 1944, 50% of
Staphylococcus aureus were resistant within six years.
Tolerance was first described in S. aureus and has since been
described with streptococci and enterococci.
Persistent Staphylococcus aureus bacteraemia is most frequently
related to S. aureus acute bacterial endocarditic, myocardial
abscess, extra cardiac abscess, or a device-associated infection.
Patients with continuous high-grade bacteraemia who do not have
acute bacterial endocarditis, an abscess, or a device-related
infection should be considered to have antimicrobial "tolerance"
as a possible cause. Antimicrobial "tolerance" is defined as a
wide discrepancy between the minimal inhibitory concentration and
the minimal bactericidal concentration of an isolate.
Despite apparent in vitro susceptibility, infections caused by
"tolerant" strains are not cured by appropriate antimicrobial
therapy. The lack of bactericidal activity of the antibiotic
becomes apparent when minimal bactericidal concentrations are
determined for "tolerant" strains, and there is a great
discrepancy between the minimal inhibitory concentrations being
used. Antibiotic tolerance to S. aureus has been described with a
variety of antibiotics. To the best of our knowledge, this is the
first case of continuous, high-grade methicillin-resistant S.
aureus bacteraemia due to a linezolid-tolerant strain (1)
Two companies invested large sums of their R&D
fund to fast track antibiotic development have failed to deliver.
It is vital that the pharmaceutical industry remains interested in
this area. Several major companies have pulled out of antibiotic
development. They have not been seen as a particularly profitable
area. If the pharmaceutical develop a new heart drug, the patient
is on it for a matter of years and resistance doesn't develop.
With
antibiotics on the other hand, the patient is on it for one or two
years and resistance may develop.
There are one or two drugs doctors can then use
as a last resort, but they are either toxic or do not work well.
Antibiotics have always had a limited lifespan because bacteria
are proficient at evolving to survive. Pfizer’s introduced
“Linezolid” in 2002 and has withdrawn this drug as high-grade
methicillin-resistant S. aureus bacteraemia has developed
tolerance. The last really effective drugs are the
carbapanems, but the bacteria are increasingly showing resistance
to them.
Alternatives to antibiotics, such as vaccines
against specific bacterial infections, had been the subject of
research but so far without a great deal of success. Staph Vac,
developed in UK has not been successful as it offered immunity for
only 45 days and is expensive. NHS is considering to use this as
prophylactic measure before performing surgical procedure.
Doctors and patients can also do their bit to
prolong the life of antibiotics by not over-using them. Health
Protection Agency advice doctors should never prescribe them and
patients should not ask for them to treat coughs and colds, which
are caused by viruses, not bacteria.
Professor Peter Borriello, director of the
HPA's centre for infections, pointed out that resistance now
spread around the world in a way it did not in past decades.
"Fifty years ago, resistance that developed in India stayed in
India," he said. "Now it can be here that week." Resistance was
inevitable, he said. "This is just evolution in real time. It just
happens quicker with bacteria than in rats and humans."
The bacteria, and the infections they can
cause, used to be confined mostly to surgical wounds in hospitals
and chronic wounds in nursing homes. But now the same
tough-to-kill bacteria are occurring in the community effecting
healthy adults and children.
About 85% of MRSA
infections can be traced back to a hospital stay and two-thirds
occur after a patient has arrived back home. But 15% of the
infections can't be linked to a hospitalization. That was the case
for my construction worker.
Initially, many
patients mistake the infection for a insect bite. The infection
forms spots that look like pimples or boils, and it can deepen and
then spread. Most of the time simple surgical drainage is all
that's needed, but other times it becomes invasive and goes
painfully deep into the surrounding tissues and even the blood
stream.
In patients with
cancer, diabetes,
eczema, immuno-compromised due chemotherapy or steroids,
infection spread rapidly all over the body. We all harbour skin
bacteria. Some bugs are worse than others. About 25% to 30% of
people carry staphylococcus aureus on the skin or in the nose and
can pass it to others. Only about 1% of the population is walking
around with MRSA. Institute of tropical medicine published a paper
claiming "Kissing
is better than shaking hands to reduce bacterial infections".
Even so, nearly
18,650 people died from MRSA infection and 94,000 others were
seriously sickened in 2005, according to the Centres for Disease
Control and Prevention.
Most hospitals have
strict policies in place to ensure that the staff uses procedures
in the fight this spreading hospital infections. Prevention is
better than treatment. Finding drugs to cure MRSA infections is a
challenge. Bacteria eventually outwit the antibiotics we throw at
them. And there's always a need for new weapons against the
resistant bugs.
Biocides, the bacteria-killing chemicals in
disinfectants and antiseptics, are universally used in hospitals
to clean surfaces, sterilise medical instruments and equipment,
and decontaminate skin before surgery. At the right levels, the
chemicals destroy most micro-organisms but if
weak doses are used
the bugs can survive and grow stronger. Bacteria have in-built
protein pumps that expel many different toxic substances,
antiseptics and antibacterial chemicals from their cells. These
"efflux pumps" are known to remove antibiotics and make bugs
drug-resistant. The CDC has voiced
concern that antibacterial cleaning products may be making the
situation worse by spurring the resistance of germs.
Researchers also exposed MRSA taken from the
blood of patients to low concentrations of several biocides and
bacteria-killing dyes. Allowing some of the bugs to survive with
the low doses meant that mutants were created which could not be
harmed by the chemicals. This discovery is bad news for hospitals, gyms
& schools trying to tackle the spread of super bugs such as
MRSA. And this explain why some find it so hard to rid themselves
of diseases, despite repeated purges.
Recurring infections
present a real challenge to doctors. The dry, flaky and irritated
skin in a child with
eczema is more than a painful irritation.
It's also an open route for MRSA they carries on her skin to reach
deeper tissues. The toddler already has multiple scars on their
legs from the boils that form below the skin. Most break open and
drain after a few days, but some of the larger ones have needed
intervention.
Some doctors are
trying forgotten methods (Potassium permangenet bathes) to
disinfect her skin. This approach, recommended by her allergist,
has helped cut down on some skin infections. Using concentrated
alcohol and other chemicals can dry skin resulting in cracks and
invasive form of infection that kill the patients. People infected
with MRSA in their skin are desperately looking for miracle cure
and have resorted to using Menuka honey, clay and various
unconventional treatment. Infected people are isolated and
confined to living indoor as prisoners in their own home (Watch
Videos published in Youtube).
MRSA spreads easily
in close quarters like classrooms, locker rooms, lunch rooms,
massage parlours and tanning beds. Athletes should shower right
after practice. The same goes for anyone using shared equipment at
the gym. The basics of MRSA
prevention are hand washing, wiping down surfaces and covering
cuts. Keeping personal care items separated from others also
helps.
Around the office,
disinfectants like bleach are often used more than antibacterial
cleaners. Scientists say hospital bacteria which can survive an
attack by disinfectants and antiseptics are becoming
ultra-resistant superbugs.They have also discovered that if too
low concentrations of antibiotics are used to kill such bugs in
patients, mutations were created that could not be killed by
drugs.
Study leader Dr Glenn Kaatz, from the
Department of Veterans Affairs Medical Centre in Detroit, USA,
said: "Because the efflux pumps also rid the cell of some
antibiotics, pathogenic bacteria with more pumps are a threat to
patients as they could be more resistant to treatment."
Bacteria have a basic survival strategy: to colonize surfaces
and grow as
bio-films communities embedded in a gel-like
poly-saccharide matrix. There is no clear figure for how many people
hospital infections such MRSA kills, but it is estimated to be as
many as 5,000 a year.
A Department of Health spokesman said:
"Antibiotic resistance is a global public health issue and we all
have a part to play in keeping our antibiotics effective.
"Bacteria will always try to find ways to
survive by evolving and developing resistance to antibiotics so we
must stay ahead of the game.
The Cannula
Cannulation involves a needle
being used to insert a tiny, flexible plastic sheath under the
skin. The needle is then removed and the medicine or fluids can be
introduced through the sheath, which remains in the blood vessels
just under the skin.
Cannula Spreading Infection:
Patients who were likely to need
IV fluids or drugs in this way were given a cannula as a routine
part of their medical care. As well as its new cannulation
procedures, the trust is implementing hand hygiene audits and deep
cleaning as ordered by the NHS.
The number of
both community acquired and hospital acquired staphylococcal
infection has increased in the past twenty years and this
trend parallels the increased use of peripheral intravascular
catheters (cannula) (4). Cannulae more often called “Venfon” are
inserted in the emergency department, had a shorter duration from
insertion to bacteraemia, and had Staphylococcus aureus more
frequently as the causative pathogen (6). A primary cause of Staph
infection in hospitals is the use of cannula (7). Infections can
occur in several different ways, including: contamination of the
device by skin flora on insertion, migration down the cannula
tract from the skin, contamination through the hub during
manipulation and seeding from another infection site.
The number of
both community acquired and hospital acquired staphylococcal
infection has increased in the past twenty years and this
trend parallels the increased use of peripheral intravascular
catheters (cannula). A primary cause of Staph infection in
hospitals is the use of cannula. Majority of septicaemia begin with
colonization of the cannula-insertion tract by bacteria from
patients own skin-flora. Doctors and nurses introducing cannula do
wash their hands but the scrubbing technique is usually ignored
and they are advised to use un-sterile gloves.
Tougher rules on the use of
intravenous cannula have been shown to cut the incidence of MRSA
infections. Winchester and Eastleigh Healthcare NHS Trust (UK) has
instead begun prescribing the insertion of cannulae. Doctors are
able to monitor the tubes more closely for signs of infection. The
trust said since the introduction last November there have been no
new cases of MRSA infections.
This figure covers all forms of
MRSA, including bloodstream infections (also known as bacteraemia)
and wound infections. This compares to 2007/08 when there was 11
reported bloodstream infections.
Implementing these changes in
every hospital is practically and ethically unacceptable. This
illustrates that simple measures, like proper skin preparation,
observe drying time, reducing the number of attempts and avoiding
ported cannula when strictly followed, can work. We could reduce
the spread of antibiotic resistant bacteria in our hospitals.

The Problem
The staff are not identifying and
locating the vein or artery prior to washing their hands. They are
advised to wear an un-sterile glove to save cost. These gloves
offer protection to staff but does not reduce the risk of
introducing infection to patients. Staff introducing a cannula
often searches for a good vein to introduce cannula needle use
disinfectants on the skin and start palpating to identify a vein
to puncture through the skin. They often palpate 2-3 locations
before they puncture the skin and strict aseptic technique are not
followed.
CDC
guidelines and observing “Drying time” (wait for 1 -2 minutes
after applying biocides). This may explain why
some find it so hard to rid themselves of diseases, despite
repeated purges
Biocides, the bacteria-killing chemicals in
disinfectants and antiseptics, are universally used in hospitals
to decontaminate skin before performing this common procedure has
developed tolerance.
Doctors and nurse are not following. At the right levels, the
chemicals destroy most micro-organisms but if weak doses are used
the bugs can survive and is often introduced through the skin into
blood vessels.
Multiple attempts to introduce cannula are traumatic and
increase the incidence of introducing infections because
adequate skin preparation is not often good in subsequent
attempts. Vascular access is essential in neonatal units,
paediatric units, A&E, ITU &
Anaesthesiology. Introducing cannula is said to be the
most common minor surgical procedure practiced in medicine. 80%
of in-patients receive treatment via a cannula during their stay
in the hospital. Since this technique was introduced in 1954,
the procedure has been a daunting, stressful to patients and
doctors. Most doctors claim to introduce a cannula in the second
attempt but our observational study show that doctors need on
average three attempts to successfully introduce a cannula in
the vein. Use of ported cannula to access vein was banned in USA
since studies demonstrated 50% of in-patients developed
bacteraemia.
NHS in UK continues to use seventeen million ported cannula ever
year. With a contamination rate often as high as 50%, stopcocks
(ports / hub) - used for medication injection, I.V. infusion
administration, and blood sample collection-represent a
potential entry portal for pathogens (14). Majority of
septicaemia begin with colonization of the cannula-insertion
tract by bacteria from patients own skin-flora (8). Mayo Clinic
Proceedings: The results show that all types of IVDs pose a risk
of bloodstream infection (BSI) and can be used for benchmarking
rates of infection caused by the various types of IVDs in use at
the present time (9).
Chhadia, AM et al; published the result of their study
CA-MRSA Hand Infections in an Urban Setting, claiming 73% of
healthy adults are said to carry this organism on their hands
(10). Up to 41% of healthcare worker’s hands sampled (after
patient care and before hand hygiene) were positive for VRE1
(11). Hand washing by hospital staff is said to be poor. Surgical
hand hygiene (or antisepsis) can be performed by using either an
antimicrobial soap OR an alcohol-based hand rubs with persistent
activity. When an antimicrobial soap is used, the hands and
forearms should be scrubbed for the length of time recommended
by the product’s manufacturer, usually 2-6 minutes.
-
Chhadia, AM;
A-MRSA Hand Infections in an Urban Setting,
Unfortunately, few clinical events have been observed in
individual studies, it remains unclear which antiseptic solution
is best, both statistically and clinically, for reducing the
risk for catheter-related blood stream infection (15). One study
found 40% of workers do not adequately wash their hands well
before performing a practical invasive procedure in patients
(13). This coupled with 53%-70% of health adults
colonising antibiotic resistant bacteria in their hand
(10) and resistance to biocides is likely to increases the
chances of introducing bacteria into blood stream resulting in
serious systemic infection. Using non-sterile gloves when
cannulation does not prevent introduction of infection.
Peripheral vascular cannulae inserted in the emergency
department caused the highest number of episodes and had a
shorter duration to bacteraemia than those inserted in other
hospital areas. This is probably due to the fact that in the
emergency department, cannulae are used excessively and are
frequently inserted under poor aseptic conditions (6).
The CDC have addressed this issue initially by recommending that
all cannulae inserted in emergency situations must be removed or
changed on hospital wards within the first 48 h of admission and
every 72 h irrespective of the presence of infection. Ward
nurses were, however, highly reluctant to change recently
inserted vascular catheters. Furthermore, other studies have
been unable to demonstrate an increased risk of complications
after three days of peripheral vascular catheterisation and have
questioned the CDC recommendation for the routine replacement of
cannulae (12, 13). Cannulae used in paediatric patients may remain
in place as long as needed, provided sites remain free of
complications (category IB). Although peripheral cannulae
insertion isn’t a sterile procedure, it requires the use of
aseptic, no-touch procedure (14).
Major cannula manufacturers are aggressively marketing their "Safety
Cannula" claiming needle stick injury is a major
occupational hazard. 196-2004, the number of staff exposed
to injuries sustained from sharp instruments were published
by occupational disease surveillance in UK. 997 were exposed to
Hepatitis C, 551 to HIV and 181 to Hepatitis B. The number of
staff contracting infections were 9 Hep C (Risk 1 in 3), Hep B
(Risk 1 in 30) and HIV (Risk 1 in 300). Comparing this with the
risk of contracting and infecting patients with antibiotic
resistant bacterial infection is very high. Nearly
18,650 people died from MRSA infection and 94,000 others were
seriously sickened in 2005, according to the Centres for Disease
Control and Prevention.
As house officers claim the success of inserting cannulae in the
first attempt is about 60% and rate improved to 90% as seniors
doctor (7). Multiple attempts to introduce cannula are traumatic
and increase the incidence of introducing infections because
adequate skin preparation is not often good in subsequent
attempts. Biocides, used in hospitals to
decontaminate skin before practical procedure if weak allow the
bacteria to survive and grow stronger. This new development is
bad news for hospital staff and patients.
Since twenty years both communities acquired and
hospital-acquired staphylococcal infections increased and this
trend parallels the increased use of intravascular device.
Vascular access development and the frequency of used technique
to save life are now threatening mankind.
1.
BA Cunha, N Mikail, and L Eisenstein; Persistent
methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia due
to a linezolid "tolerant" strain. Heart Lung, September 1, 2008;
37(5): 398-400)
2.
Aislinn Simpson ; Hospital bacteria such
as MRSA becoming resistant to disinfectants. UK Telegraph, Last
Updated: 6:46AM BST 06 Oct 2008)
3. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in
nosocomial primary bloodstream infections in US, 1980-1989. Am J
Med 1991; 91; Suppl 3B:3B-86S-3B-89S
4.
Steinberg JP, Clark CC, Hackman BO. Nosocomial and community
acquired Staphylococcal aureus bacteraemia from 1980 to 1993:
impact of intravascular devices and methicillin resistance. Clin
Infect Disease 1996; 23: 255-9.
5. Pujol M, Hornero A, Saballs A, Argerich MJ, Verdaguer R, Cisnal
M, Peña C, Ariza J, Gudiol F.
Clinical epidemiology and outcomes of
peripheral venous catheter-related bloodstream infections at a
university hospital;
Journal of
Hospital Infection (2007); 67, 22-29.
5. Maki D, Ringer M, Alvarado C. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of
infection associated with CV and Arterial catheter. Lancet (1991);
338: 339-343.
6. Mimoz O, Pieroni I, Lawrence C, et al. Prospective randomized
trial of two antiseptic solutions for preventing CV or arterial
colonization and infection in intensive care unit patients. Crit
Care Med. 1996; 24: 1818-1823.
7. Crnich, Christopher J; Kluger, Daniel M; Maki, Dennis G ; The
Risk of Bloodstream Infection in Adults With Different
Intravascular Devices: A Systematic Review of 200 Published
Prospective Studies.Mayo Clinic Proceedings, September 1, 2006)
8. Chhadia AM; Gonzalez MH; Rudy K, et al; Community Associated
Methicillin-Resistant Staphylococcus aureus Hand Infections in an
Urban Setting; The Journal of Hand Surgery, March 2007.
9. Hayden MK, Clin Infect Diseases 2000;31:1058-1065).
10. Bregenzer T, Conen D, Sakmann P, Widmer A. Is routine
replacement of peripheral intravenous catheters necessary? Arch
Intern Med 1998; 158:151-156.).
11. Humar, A., et al.: Prospective Randomized Trial of 10%
Povidone-Iodine Versus 0.5% Tincture of Chlorhexidine as Cutaneous
Antisepsis for Prevention of Central Venous Catheter Infection,
Journal of Clinical Infectious Diseases. 31:1001-1007, 2000.
Miki DG et al; Prospective randomised trial of povidone-iodine,
alcohol, and chlorhexidine for prevention of infection associated
with central venous and arterial catheters.
- Comment in:
-
Lancet. 1991 Nov 9;338(8776):1218-9.
-
Lancet. 1991 Sep 7;338(8767):635.
-
-
Chlorhexidine-based antiseptic solution vs alcohol-based
povidone-iodine for central venous catheter care.
12. Kelli R, Pinpointing intravascular device infections; Nursing
Management (Springhouse): Volume 34(6) June 2003pp 35-42.
13. Mimoz O, Pieroni I, Lawrence C, et al. Prospective randomized
trial of two antiseptic solutions for preventing CV or arterial
colonization and infection in intensive care unit patients. Crit
Care Med. 1996; 24: 1818-18
14.
S Ladhani, O S Konana, S Mwarumba, M C English; Bacteraemia due to
Staphylococcus aureus.
15.
Impact of Methicillin Resistance on the Outcome of Severe
Staphylococcus aureus Infections
16.
Joseph M. Mylotte and Ammar Tayara. Staphylococcus aureus
Bacteremia: Predictors of 30-Day Mortality in a Large Cohort;
Clinical Infectious Diseases
2000;31:1170–1174. © 2000 by the Infectious Diseases Society of
America
17.
Thomas Bregenzer, MD; Dieter Conen, MD; Pascal Sakmann, MD;
Andreas F. Widmer, MD, MS; Is Routine Replacement of Peripheral
Intravenous Catheters Necessary? Arch Intern
Med. 1998;158:151-156.
18. Gary R. Collin , MD; Decreasing Catheter Colonization Through
the Use of an Antiseptic-Impregnated Catheter* Chest.
1999;115:1632-1640.© 1999 American College of Chest Physicians
19.
Michele L. Pearson, MD, and Elias Abrutyn, MD ; Reducing the Risk
for Catheter-Related Infections: A New Strategy. 15 August 1997 |
Volume 127 Issue 4 | Pages 304-306
20. R.J. Pratta*, C.M. Pellowea, J.A. Wilsona,b, H.P. Lovedaya,
P.J. Harpera, S.R.L.J. Jonesa, C. McDougallb, M.H. Wilcoxc;
National Evidence-Based Guidelines for Preventing
Healthcare-Associated Infections in NHS Hospitals in England;
Journal of Hospital Infection (2007) 65S, S1–S64;
http://www.epic.tvu.ac.uk/PDF%20Files/epic2/epic2-final.pdf
|